Back to User profile » Dr Gary T Ferguson
Papers published by Dr Gary T Ferguson:
Healthcare Resource Utilization, Cost and Clinical Outcomes in Patients Diagnosed with COPD Initiating Tiotropium Bromide/Olodaterol versus Fluticasone Furoate/Umeclidinium/Vilanterol Based on Exacerbation History
Sethi S, Clark B, Bengtson LG, Buysman EK, Palli S, Sargent A, Shaikh A, Ferguson GT
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:625-641
Published Date: 19 April 2023
Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease
Ohar JA, Ferguson GT, Mahler DA, Drummond MB, Dhand R, Pleasants RA, Anzueto A, Halpin DMG, Price DB, Drescher GS, Hoy HM, Haughney J, Hess MW, Usmani OS
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:79-92
Published Date: 6 January 2022
TRONARTO: A Randomized, Placebo-Controlled Study of Tiotropium/Olodaterol Delivered via Soft Mist Inhaler in COPD Patients Stratified by Peak Inspiratory Flow
Mahler DA, Ludwig-Sengpiel A, Ferguson GT, de la Hoz A, Ritz J, Shaikh A, Watz H
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2455-2465
Published Date: 28 August 2021
A Dose-Ranging Study of the Novel Inhaled Dual PDE 3 and 4 Inhibitor Ensifentrine in Patients with COPD Receiving Maintenance Tiotropium Therapy
Ferguson GT, Kerwin EM, Rheault T, Bengtsson T, Rickard K
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1137-1148
Published Date: 22 April 2021
Peak Inspiratory Flow Rate in COPD: An Analysis of Clinical Trial and Real-World Data
Anderson M, Collison K, Drummond MB, Hamilton M, Jain R, Martin N, Mularski RA, Thomas M, Zhu CQ, Ferguson GT
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:933-943
Published Date: 12 April 2021
Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Exacerbation Outcomes in Patients with COPD without a Recent Exacerbation History: A Subgroup Analysis of KRONOS
Martinez FJ, Ferguson GT, Bourne E, Ballal S, Darken P, Aurivillius M, Dorinsky P, Reisner C
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:179-189
Published Date: 28 January 2021
Unreported and Overlooked: A Post Hoc Analysis of COPD Symptom-Related Attacks from the RISE Study
Ferguson GT, Skärby T, Nordenmark LH, Lamarca R, Aksomaityte A, Lythgoe D, Gilbert I, Trudo F
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:3123-3134
Published Date: 27 November 2020
Effect of Inhaled Corticosteroid Withdrawal on Chronic Obstructive Pulmonary Disease Exacerbations in Patients Taking Triple Therapy at Baseline
Ferguson GT, Shaikh A, Tetzlaff K, Mueller A, Magnussen H, Watz H
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2879-2888
Published Date: 11 November 2020
Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD
Ichinose M, Fukushima Y, Inoue Y, Hataji O, Ferguson GT, Rabe KF, Hayashi N, Okada H, Takikawa M, Bourne E, Ballal S, DeAngelis K, Aurivillius M, Reisner C, Dorinsky P
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2993-3002
Published Date: 23 December 2019
Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study
Ichinose M, Fukushima Y, Inoue Y, Hataji O, Ferguson GT, Rabe KF, Hayashi N, Okada H, Takikawa M, Bourne E, Ballal S, DeAngelis K, Aurivillius M, Dorinsky P, Reisner C
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2979-2991
Published Date: 23 December 2019
Two-Year Integrated Efficacy And Safety Analysis Of Benralizumab In Severe Asthma
FitzGerald JM, Bleecker ER, Bourdin A, Busse WW, Ferguson GT, Brooks L, Barker P, Martin UJ
Journal of Asthma and Allergy 2019, 12:401-413
Published Date: 9 December 2019
Single-Use Autoinjector Functionality And Reliability For At-Home Administration Of Benralizumab For Patients With Severe Asthma: GRECO Trial Results
Ferguson GT, Cole J, Aurivillius M, Roussel P, Barker P, Martin UJ
Journal of Asthma and Allergy 2019, 12:363-373
Published Date: 23 October 2019
AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD
Sethi S, Kerwin E, Watz H, Ferguson GT, Mroz RM, Segarra R, Molins E, Jarreta D, Garcia Gil E
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:667-682
Published Date: 22 March 2019
Effects of baseline symptom burden on treatment response in COPD
Martinez FJ, Abrahams RA, Ferguson GT, Bjermer L, Grönke L, Voß F, Singh D
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:181-194
Published Date: 4 January 2019
Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting β2-agonist via dry-powder inhalers and pressurized metered-dose inhalers
Wittbrodt ET, Millette LA, Evans KA, Bonafede M, Tkacz J, Ferguson GT
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:101-114
Published Date: 24 December 2018
Assessment of an accessorized pre-filled syringe for home-administered benralizumab in severe asthma
Ferguson GT, Mansur AH, Jacobs JS, Hebert J, Clawson C, Tao W, Wu Y, Goldman M
Journal of Asthma and Allergy 2018, 11:63-72
Published Date: 5 April 2018
Pharmacokinetics of glycopyrronium/formoterol fumarate dihydrate delivered via metered dose inhaler using co-suspension delivery technology in patients with moderate-to-very severe COPD
Ferguson GT, Rodriguez-Roisin R, Reisner C, Maes A, Siddiqui S, Martin UJ
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:945-953
Published Date: 21 March 2018
Efficacy and safety of tiotropium + olodaterol maintenance treatment in patients with COPD in the TONADO® and OTEMTO® studies: a subgroup analysis by age
Ferguson GT, Karpel JP, Clerisme-Beaty E, Grönke L, Voß F, Buhl R
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:2701-2710
Published Date: 31 October 2016
Efficacy and safety of olodaterol once daily delivered via Respimat® in patients with GOLD 2–4 COPD: results from two replicate 48-week studies
Ferguson GT, Feldman GJ, Hofbauer P, Hamilton A, Allen L, Korducki L, Sachs P
International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:629-645
Published Date: 16 June 2014
COPD patient satisfaction with ipratropium bromide/albuterol delivered via Respimat: a randomized, controlled study
Ferguson GT, Ghafouri M, Dai L, Dunn LJ
International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:139-150
Published Date: 19 March 2013